0 valutazioniIl 0% ha trovato utile questo documento (0 voti)
13 visualizzazioni1 pagina
This document is a list from the EPA of products with emerging viral pathogen claims for use against SARS-CoV-2. It includes the EPA registration number, active ingredients, product name, company, follow disinfection directions, contact time, formulation type, surfaces, use sites, whether the product has an emerging viral pathogen claim, and date added to the list. The only product listed is Aseptrol S10-Tab by BASF Corporation which has sodium chlorite and sodium dichloroisocyanurate dihydrate as active ingredients and is a solid formulation effective against feline calicivirus in 10 minutes on hard, nonporous surfaces in healthcare, institutional, and residential settings.
Descrizione originale:
Titolo originale
List N Products with Emerging Viral Pathogens AND Human Coronavirus claims for use against SARS-CoV-2Date Accessed 04032020 (1)
This document is a list from the EPA of products with emerging viral pathogen claims for use against SARS-CoV-2. It includes the EPA registration number, active ingredients, product name, company, follow disinfection directions, contact time, formulation type, surfaces, use sites, whether the product has an emerging viral pathogen claim, and date added to the list. The only product listed is Aseptrol S10-Tab by BASF Corporation which has sodium chlorite and sodium dichloroisocyanurate dihydrate as active ingredients and is a solid formulation effective against feline calicivirus in 10 minutes on hard, nonporous surfaces in healthcare, institutional, and residential settings.
This document is a list from the EPA of products with emerging viral pathogen claims for use against SARS-CoV-2. It includes the EPA registration number, active ingredients, product name, company, follow disinfection directions, contact time, formulation type, surfaces, use sites, whether the product has an emerging viral pathogen claim, and date added to the list. The only product listed is Aseptrol S10-Tab by BASF Corporation which has sodium chlorite and sodium dichloroisocyanurate dihydrate as active ingredients and is a solid formulation effective against feline calicivirus in 10 minutes on hard, nonporous surfaces in healthcare, institutional, and residential settings.
List N: Products with Emerging Viral Pathogens AND Human Coronavirus claims for use against SARS-CoV-2
Date Accessed: 04/03/2020
EPA Active Ingredient(s) Product Company Follow the Contact Formulation Surface Use Site Emerging Date Registration Name disinfection Time (in Type Types for Viral Added to Number directions and minutes) Use Pathogen List N preparation for Claim? the following virus 70060-19 Sodium chlorite; Sodium Aseptrol BASF Feline calicivirus 10 Solid Hard Healthcare; Yes 03/26/2020 dischloroisocyanurate S10-Tab Corporation nonporous Institutional; dihydrate Residential
www.epa.gov/pesticide-registration/list-n-disinfectants-use-against-sars-cov-2 1 of 1